argus

Indoco Remedies Ltd.

NSE: INDOCOINE873D010242,244 Cr

Timeline

Time (IST)TypeMEventSrc
01 Sept, 10:46 amshareholding_change1Aditi M Panandikar and Madhura Suresh Kare (PAC) acquired 10,000 equity shares (0.01% of total voting capital) from the open market, increasing their combined holding from 5.85% to 5.86%.bse
27 Aug, 04:28 pmIndoco Remedies Limited has informed the Exchange about execution of Deed of Conveyance for Sale of Company's plot of land.nse
27 Aug, 04:01 pmIndoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreementsbse
21 Aug, 03:45 pmIndoco Remedies Limited has informed the Exchange regarding 'Business Responsibility & Sustainability report for the financial year 2025-2026'.nse
21 Aug, 03:04 pmIndoco Remedies Ltd - 532612 - Reg. 34 (1) Annual Report.bse
21 Aug, 12:25 pmIndoco Remedies Limited has informed the Exchange that Record date for the purpose of Dividend is 10-Sep-2026.nse
21 Aug, 12:13 pmIndoco Remedies Ltd - 532612 - Intimation Of Cut-Off Date For E-Voting, Book Closure And Record Date For Dividendbse
04 Aug, 12:04 pmIndoco Remedies Limited has informed the Exchange about Transcriptnse
04 Aug, 11:59 amIndoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
28 Jul, 06:32 pmIndoco Remedies Limited has informed the Exchange about Link of Recordingnse
28 Jul, 06:25 pmIndoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
28 Jul, 12:04 pmIndoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Change in Managementbse
28 Jul, 12:01 pmIndoco Remedies Limited has informed the Exchange regarding Appointment of Mr SUDHIR KADAM as SENIOR MANAGEMENT PERSONNEL DESIGNATED AS SR. VICE PRESIDENT (HUMAN CAPITAL) of the company w.e.f. July 28, 2026.nse
28 Jul, 11:59 amIndoco Remedies Ltd - 532612 - Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June, 2026 Along With Limited Review Reportbse
28 Jul, 11:57 amIndoco Remedies Limited has informed the Exchange regarding Reappointment of Mrs ADITI PANANDIKAR as Managing Director of the company w.e.f. February 15, 2027.nse
28 Jul, 11:55 amIndoco Remedies Ltd - 532612 - Board Meeting Outcome for Outcome Of Board Meeting Held On 28Th July, 2026bse
28 Jul, 11:54 amIndoco Remedies Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.nse
15 Jul, 12:49 pmIndoco Remedies Ltd - 532612 - Board Meeting Intimation for Unaudited Results For The Quarter Ended 30-06-2026bse
26 Jun, 12:20 pmIndoco Remedies Limited has informed the Exchange regarding a press release dated Jun 26, 2026, titled "Indoco Remedies Goa Plant successfully clears Malta Medicines Authority audit".nse
26 Jun, 12:15 pmIndoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
28 May, 04:23 pmIndoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
28 May, 04:18 pmIndoco Remedies Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Indoco's formulation plant at Baddi (Plant III) receives EU GMP Certification".nse
22 May, 09:19 amIndoco Remedies Ltd - 532612 - Compliances-Reg.24(A)-Annual Secretarial Compliancebse
18 May, 08:14 pmIndoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreementsbse
18 May, 08:11 pmIndoco Remedies Limited has informed the Exchange about Completion of transfer of its Ophthalmic Division to Sunways (India) Private Limitednse
15 May, 12:20 pmIndoco Remedies Limited has informed the Exchange regarding Demise of Mr Anand Nadkarni , Non- Executive Director of the company on May 15, 2026.nse
15 May, 11:57 amIndoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Demisebse
14 May, 11:03 amIndoco Remedies Limited has informed the Exchange regarding a press release dated May 14, 2026, titled "Indoco Remedies successfully clears Malta Medicines Authority audit".nse
14 May, 11:02 amIndoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
11 May, 11:15 amIndoco Remedies Limited has informed the Exchange about Transcriptnse
11 May, 11:08 amIndoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
07 May, 06:50 pmIndoco Remedies Limited has informed the Exchange about Link of Recordingnse
07 May, 06:42 pmIndoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
07 May, 12:39 pmIndoco Remedies Ltd - 532612 - Audited Standalone And Consolidated Financial Results For The Quater And Year Ended 31St March, 2026bse
07 May, 12:36 pmIndoco Remedies Limited has informed the Exchange that Board of Directors at its meeting held on May 07, 2026, recommended Final Dividend of Rs. 0.20 per equity share.nse
07 May, 12:34 pmIndoco Remedies Ltd - 532612 - Board Meeting Outcome for Outcome Of Board Meeting Held On 07Th May, 2026bse
07 May, 12:33 pmIndoco Remedies Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.nse
30 Apr, 07:53 pmIndoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreementsbse
30 Apr, 07:50 pmIndoco Remedies Limited has informed the Exchange about Intimation regarding execution of Agreement to Transfer Business with Sunways (India) Private Limitednse
30 Apr, 07:26 pmIndoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
30 Apr, 07:25 pmIndoco Remedies Limited has informed the Exchange regarding a press release dated April 30, 2026, titled "Indoco Remedies announces strategic transfer of its ophthalmic division to Sunways India ".nse
30 Apr, 06:38 pmIndoco Remedies Limited has informed the Exchange about Approval of Agreement to Transfer Businessnse
30 Apr, 06:33 pmIndoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreementsbse
27 Apr, 03:47 pmIndoco Remedies Limited has informed the Exchange about ECC on Audited Financial Results for the quarter and year ended 31-03-2026nse
27 Apr, 01:30 pmIndoco Remedies Ltd - 532612 - Board Meeting Intimation for Board Meeting Intimation For Audited Results & Dividendbse
13 Apr, 06:47 pmIndoco Remedies Limited has informed the Exchange about Update on the Company's testing facility at Chhatrapati Sambaji Nagar (Aurangabad)nse
31 Mar, 01:25 pmIndoco Remedies Limited has informed the Exchange about re-appointment of Cost Auditor and Internal Auditor.nse
31 Mar, 01:23 pmIndoco Remedies Ltd - 532612 - Announcement Under Regulation 30 Of SEBI LODR-- Intimation Of Re-Appointment Of Cost Auditor And Internal Auditor Of The Companybse
24 Feb, 11:50 amIndoco Remedies Limited has informed the Exchange regarding a press release dated February 24, 2026, titled "Indoco Remedies receives final ANDA approval from USFDA for Brivaracetam Oral Solution, 10 mg/mL".nse
24 Feb, 11:46 amIndoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse